Robert Michael Anthenelli MD
Addiction
Professor, Department of Psychiatry, University of California, San Diego, School of Medicine; Director, Pacific Treatment and Research Center; La Jolla, CA
Join to View Full Profile
200 W Arbor DrSan Diego, CA 92103
Phone+1 800-926-8273
Fax+1 888-539-8781
Dr. Anthenelli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Robert Anthenelli is a Professor of Psychiatry at the University of California, San Diego, School of Medicine where he directs the Pacific Treatment and Research Center. He received his medical degree from the Johns Hopkins University School of Medicine and did his residency and fellowship at UC San Diego and VA San Diego Healthcare System. He specializes in addiction psychiatry.
Education & Training
University of California (San Diego) Medical CenterResidency, Psychiatry, 1987 - 1990
Johns Hopkins University School of MedicineClass of 1986
Certifications & Licensure
CA State Medical License 1988 - 2025
OH State Medical License 1986 - 2021
American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Alcohol and Gender Effects on Stress Circuit Function Start of enrollment: 2003 Sep 01
- Predicting Alcoholics' Treatment Responses to a Selective Serotonin Re-uptake Inhibitor (SSRI) Start of enrollment: 2005 Feb 01
- Topiramate to Aid Smoking Cessation in Alcohol Dependent Men Start of enrollment: 2009 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- A Randomized Clinical Trial of Prolonged Exposure Therapy With and Without Topiramate for Comorbid PTSD and Alcohol Use Disorder.Sonya B Norman, Matthew T Luciano, Kaitlyn E Panza, Brittany C Davis, Michelle Lyons
The American Journal of Psychiatry. 2025-03-19 - Effects of Varenicline, Bupropion, Nicotine Patch, and Placebo on Treating Smoking Among Persons With Current or Past Major Depressive Disorder: Secondary Analysis of ...George Kypriotakis, Paul M Cinciripini, Charles E Green, David Lawrence, Robert M Anthenelli
The American Journal of Psychiatry. 2025-02-01 - 1 citationsDo tobacco regulatory and economic factors influence smoking cessation outcomes? A post-hoc analysis of the multinational EAGLES randomised controlled trial.Belinda Daniel, David E Lawrence, Benjamin S McKenna, Phillip Saccone, Thomas McRae
BMJ Open. 2024-09-20
Journal Articles
- Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in SmokersRobert M Anthenelli, Neal L Benowitz, JAMA
Press Mentions
$11.4 Million NIH Grant Advances Drug to Treat Nicotine AddictionSeptember 16th, 2020- Zafiris J. Daskalakis, MD, PhD, Named Chair of the Department of PsychiatryJuly 30th, 2020
Study Identifies Predictors of Psychiatric Events During Drug-Assisted Smoking CessationFebruary 27th, 2019- Join now to see all
Grant Support
- Safety/Toxicology, ADME and CMC Activities to Support the Assessment of the mGlu2 PAM SBP-9330 in a Phase 2 Clinical Study in SmokersSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE2023–2026
- Safety/Toxicology, ADME and CMC Activities to Support the Assessment of the mGlu2 PAM SBP-9330 in a Phase 2 Clinical Study in SmokersSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE2023–2026
- Safety/Toxicology, ADME and CMC Activities to Support the Assessment of the mGlu2 PAM SBP-9330 in a Phase 2 Clinical Study in SmokersSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE2023–2026
- Clinical development of an mGlu2 positive allosteric modulator to treat nicotine addictionSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE2020–2025
- Exploring Potential Sex Differences In Neurobiological Mechanisms of Alcohol Sensitivity and ToleranceUNIVERSITY OF CALIFORNIA, SAN DIEGO2020–2025
- New Pharmacotherapy For Alcohol And Co-Morbid DisordersNational Institute On Alcohol Abuse And Alcoholism2010–2011
- Predicting Alcoholics'Treatment Responses To An SSRINational Institute On Alcohol Abuse And Alcoholism2004–2008
- Alcohol And Gender Effects On Stress Circuit FunctionNational Institute On Alcohol Abuse And Alcoholism2003–2008
- Scientific Review And Evaluation AwardNational Institute On Alcohol Abuse And Alcoholism2004
- Clinically Relevant Markers Of Alcoholic SubgroupsNational Institute On Alcohol Abuse And Alcoholism1996–1997
- Clinically Relevant Markers Of Alcoholic SubgroupsNational Institute On Alcohol Abuse And Alcoholism1993–1996
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
